Literature DB >> 10363806

Evaluation of methods for large scale preparation of antibody ligand conjugates.

C Wu1, O A Gansow, M W Brechbiel.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10363806     DOI： 10.1016/s0969-8051(98)00112-7

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN： 0969-8051            Impact factor:   2.408


× No keyword cloud information.
  7 in total

1.  Exploration of a F(ab')2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy.

Authors:  Diane E Milenic; Young-Seung Kim; Kwamena E Baidoo; Karen J Wong; Rachel Barkley; Jose Delgado; Martin W Brechbiel
Journal:  Cancer Biother Radiopharm       Date:  2018-06       Impact factor: 3.099

2.  Strategies for labeling proteins with PARACEST agents.

Authors:  Olga Vasalatiy; Piyu Zhao; Mark Woods; Andrei Marconescu; Aminta Castillo-Muzquiz; Philip Thorpe; Garry E Kiefer; A Dean Sherry
Journal:  Bioorg Med Chem       Date:  2010-06-18       Impact factor: 3.641

3.  90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Authors:  John E Janik; John C Morris; Deirdre O'Mahony; Stefania Pittaluga; Elaine S Jaffe; Christophe E Redon; William M Bonner; Martin W Brechbiel; Chang H Paik; Millie Whatley; Clara Chen; Jae-Ho Lee; Thomas A Fleisher; Maggie Brown; Jeffrey D White; Donn M Stewart; Suzanne Fioravanti; Cathryn C Lee; Carolyn K Goldman; Bonita R Bryant; Richard P Junghans; Jorge A Carrasquillo; Tat'Yana Worthy; Erin Corcoran; Kevin C Conlon; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

4.  Rapid and efficient production of radiolabeled antibody conjugates using vacuum diafiltration guided by mathematical modeling.

Authors:  Derek W Bartlett; David Colcher; Andrew A Raubitschek
Journal:  Bioconjug Chem       Date:  2008-08-23       Impact factor: 4.774

5.  Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease.

Authors:  Diane E Milenic; Kwamena E Baidoo; Young-Seung Kim; Rachel Barkley; Martin W Brechbiel
Journal:  Dalton Trans       Date:  2017-10-31       Impact factor: 4.390

6.  High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.

Authors:  Tobias Weber; Benedikt Bötticher; Walter Mier; Max Sauter; Susanne Krämer; Karin Leotta; Armin Keller; Anne Schlegelmilch; Ludger Grosse-Hovest; Dirk Jäger; Uwe Haberkorn; Michaela A E Arndt; Jürgen Krauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

Review 7.  An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.

Authors:  Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Krolicki; Frank Bruchertseifer
Journal:  Curr Radiopharm       Date:  2018
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.